CA2106257A1 - Universal tined myocardial pacing lead - Google Patents
Universal tined myocardial pacing leadInfo
- Publication number
- CA2106257A1 CA2106257A1 CA002106257A CA2106257A CA2106257A1 CA 2106257 A1 CA2106257 A1 CA 2106257A1 CA 002106257 A CA002106257 A CA 002106257A CA 2106257 A CA2106257 A CA 2106257A CA 2106257 A1 CA2106257 A1 CA 2106257A1
- Authority
- CA
- Canada
- Prior art keywords
- lead
- tines
- distal end
- tine means
- conductor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
ABSTRACT
A myocardial pacing lead include two sets of at least two tines placed to oppose each other. The lead is pressed against the epicardium and is rotated until a rough porous tip abrades the epicardium and allows the tip and the first row of tines to penetrate the myocardium. Excessive penetration and lead migration is prevented by the second row of tines which is mounted backward and just proximal from the first row of tines. The first row of tines anchor on the inside surface of the epicardium which prevents dislodgment. Dacron pads on the second row of tines assures chronic fixation by adhering to the outer surface of the patient's epicardium.
A myocardial pacing lead include two sets of at least two tines placed to oppose each other. The lead is pressed against the epicardium and is rotated until a rough porous tip abrades the epicardium and allows the tip and the first row of tines to penetrate the myocardium. Excessive penetration and lead migration is prevented by the second row of tines which is mounted backward and just proximal from the first row of tines. The first row of tines anchor on the inside surface of the epicardium which prevents dislodgment. Dacron pads on the second row of tines assures chronic fixation by adhering to the outer surface of the patient's epicardium.
Description
~11 a62~7 -A IJNIVER8A~ q!INED MYOCARDIA~ PACING L~5AD
FIELD OF THE INVENTION
The pre~ent invention relates to a medical electrode lead and more particularly to a myocardial pacing lead employing a tip configuration to prevent excessive penetration into a patient's myocardium.
BACKGROUND OF THE INVENTION
Electrical ~timulation of the body for medical purposes i5 well known in the prior art. An example of a device for this purposs i8 the well known cardiac pacemaker. In general, pacemakers employ an electrode that is maintained in contact with a patient's heart muscle, through which electrical stimulation of the heart muscle is achieved. Such pacemakers commonly employ a flexible conductive lead that connects a remotely positioned and implanted power source to the electrode tip. The lead i8 typically routed to achieve either passive or active fixation to the heart muscle. Active fixation means such as corkscrew~ or hooks have been used to maintain the electrode tip in contact with the heart muscle.
Alternatively, passive fixation means have been employed to temporarily hold the electrode tip in contact with the heart muscle untll sufficient tissue ingrowth has occurred about the electrode tip to hold it in place. Such a passive device is disclosed in Citron et al. U.S. Pat. No. 3,902,501, who provide a plurality of pliant tines extending from the electrode adjacent the tip and forming an acute angle with respect to the electrode body. The tines cooperate with the trabeculae in the heart muscle to hold the electrode tip in position until such time as natural fixation has occurred.
Interactions between the lead and the patient's bcdy can vitiate the desired effects of the stimulation. For example, biolcgic reactions encourage fibrosis. Furthermore, trauma results in inflammation of the tissue to be stimulated. Other P-1972 2 2~6~
interactions between the lead and body, while not directly affecting the response of the tissue to the ~timulation energy, can result in the occurrence of undesirable svents.
The placement of a lead may compound certain events such as irritability.
Efforts have been made to ameliorate the undesirable consequences of interactions between lead and body. For example, leads have been configured to reduce mechanical trauma and the response of the irritable tissue during lead placement. Materials have been selected for the lead body and ele¢trodes to minimize fibrosis. However, lead configuration must take into account other factors such as the ease of placement, maintenance of the desired electrode position and the reliability of the lead over extended periods of time.
lS Undesirable interactions between lead and body are a particular problem in the context of a myocardial lead employing a penetrating electrode, especially in the area of pediatrics. Unlike the electrodes of most endocardial leads, penetrating myocardial electrodes are intended to function by insertion into the tissue, rather than by placement against the tissue. As such, the basic mode of operation of these electrodes requires some small amount of tissue damage to accompany attachment of the electrode. The greater the reaction of the heart tissue to this injury, the more likely it is that subsequent problems of increased threshold, fibrosis or irritability will rise. This is particularly true in the area of pediatrics. Thus, there is a need for a low threshold, high pacing impedance myocardial lead suitable for pediatrics.
SUMMARY OF THE INVENTION
The present invention provides a body implantable high impedance, low threshold, tined, myocardial lead for the delivery of stimulation energy suitable for use in adult and pediatric applications. In one embodiment, a high impedance, 3 ~ `7 low threshold, steroid eluting lead with a rough porous tip, includes two sets of at least two tines placed to oppose each other. The lead (with stylet) is pressed against the epicardium and is rotated. The rough porous tip abrades the epicardium and allows the tip and the first row of tines to penetrate the myocardium. Excessive penetration and lead migration is prevented by the second row of tines which is mounted backward and just proximal from the firæt row of tines. The first row of tines anchor on the inside surface of the epicardium thereby preventing dislodgment. Withdrawal of the stylet allows the lead to assume any existent preformed ~hape. Dacron pads on the second row oS tine~ assures chronic fixation by adhering to the outer surface o~ the patient~s epicardium. Controlling the depth of the first row of tines allows for chronic removal by counter traction without tearing or otherwise damaging the heart.
Another e~bodiment allows a similar lead to be implanted transvenously to provide positive or passive fixation.
Positive fixation is achieved by applying sliqht pressure and rotating the lead until the tip pops into the endocardium as far as the first row of tines will allow. Pas6ive fixation is achieved by simply placing the lead as any other prior art tined lead is placed.
Thus, the inventive lead can achieve the implant characteristics of an epicardial lead, a transvenous tined lead or a transvenous active fixation lead.
BRIEF DESCRIPTION OF THE DR~WINGS
FIG. 1 illustrates a side view of the distal end portion of a tined lead with a single row of tines as is already known in the prior art.
FIG. 2 illustrates active fixation of the distal end portion of the prior art tined lead depicted in FI~. 1 to a myocardium.
FIG. 3 illustrates a side view of the distal end portion of a preferred embodiment of the present invention.
FIG. 4 illustrates an end view of the distal end portion of a preferred embodiment of the present invention.
FIG. 5 illustrates active fixation of the distal end portion of a preferred embodiment of the present invention to a myocardium.
FIG. 6 illustrateæ another side view of the distal end portion of a preferred embodiment of the present invention depictlng optimal dimensional criteria.
FIG. 7 illustrates a preferred embodiment of the present lnvention ~ubsequent to active fixation to a myocardium and following removal of an insertion stylet, thereby allowing the preferred embodiment of the present invention to assume a stablQ preformed right angle shape.
DETAILED DESCRIPTION OF THE INVENTION
Referring now to FIGURE 1, there is illustrated a body implantable tined lead already known in the prior art. Tined leads such as this one are passively attached to heart muscle without penetrating the myocardium. An example of such a lead i8 disclosed in U.S. Patent Number 4,269,198 issued to Stokes.
Active fixation of a lead such as the lead invented by Stokes is illustrated in FIGURE 2. This type of application, with a single row of tines, has no means for preventing migration of the lead within the myocardium. Additionally, no means exist in such an application for controlling the depth of the lead into the myocardium for procuring active fixation.
Controlling the depth of active fixation into the myocardium and preventing migration of the lead tip subsequent to lead fixation become even more significant implant concerns in the area of pediatrics where patient organs are smaller and more fragile than fully developed adult organsO
Moving n~w to FIGURE 3, there is illustrated a side view of the distal end of a preferred embod-ment of the present 62~7 inventive lead capable of both controlling the depth of active fixation into a myocardium and preventing migration of the lead tip, effective in adult and paediatric applications. The proximal end, not shown, is coupled to an electrical connector such as those known in the prior art. The preferred embodiment, illustrated in FIGURE 3, also comprises an electrical conductor, not shown, within the insulating sheath 1. A tip electrode 9, preferably having a surface area less than 4.0 mm2, is provided at the distal end of the lead assembly 10 in a manner described in pending Canadian application Serial No. 2,085,369 for MINIATURE
STEROID ELUTING PACING LEAD ELECTRODES which has been assigned to Medtronic, Inc. Proximal to electrode 9, is a row of standard tines 3, identical to those shown in FIGURE 1 and already known in the prior art, formed of a pliant material which is generally inert to body fluids; silicone rubber or polyurethane, for example. The tines 3, are attached to the body member 1, in the traditional manner known in the prior art. The tines 3, may take any acute angle with the proximal end of body member 1, their purpose being to anchor to the inside wall of the epicardium, thereby preventing accidental dislodgment and maintaining the tip 9, in electrical contact with the myocardium. A second row of backward mounted tines 7, proximal the first row of tines 3, is located between the proximal end of lead assembly 10 and the first row of tines 3. The tines 7, in the second row must be longer than tines 3, in the first row to allow implantation into the myocardium. Tines 7 on the lead body 1 form an acute angle with body member 1 which is in opposition to the acute angle formed by tines 3 and body member 1. Additionally, tines 7 have dacron pads 5 attached to their free floating P-1972 6 ~ 2 ~ 7 ends for assuring chronic fixation of tines 7 to the outside wall of the epicardium.
Referring now to FIGURE 4, there is illustrated an end view of the preferred embodiment of the present inventive myocardial lead of FIGURE 3 as seen from the distal end containing tip electrode 9. Although four tines 3 are depicted in the first row, and four tines 7 are depicted in the ~econd row, any number of tines may be used, two or more being adequate in most situations. Furthermore, it is preferable to have the tines 3 in the first row alternately and evenly spaced with the tines 7 in the second row as indicated in FIG. 4, although such spacing and tine placement is not required for the present invention to function properly.
FIGURE S illustrates active fixation of the preferred embodiment of the present inventive tined myocardial pacing lead to a myocardium. Utilizing a stylet, the lead assembly 10 is pressed against the epicardium and is rotated. The rough porous tip 9 abrades the epicardium and allows the tip 9 and the first row of tines 3 to penetrate the myocardium.
The combination of pushing the tip electrode 9 toward the epicardium while rotating the electrode 9 at the same time r~sults in only a gentle and significantly less force required to perforate the epicardium as compared to simply pushing the electrode 9 into the epicardium to achieve myocardial penetration. Excessive penetration into the myocardium i8 prevented by the second row of tines 7. The first row of tines 3 anchor on the inside wall of the epicardium thereby preventing accidental dislodgment without use of sufficient external force. Chronic fixation of the lead assembly 10 is achi2vsd by dacron pads 5 which adhere to the outside wall of the epi~ardium in as a result of fibrosis Thus, controlling the dep~h of tip electrode 9 penetration into the myocardium, thereby ensuring the anchoring position of the first row of tines 3, further ensures that chronic removal of lead assembly 2~0~2~7 10 by counter traction can be accomplished without tearing or otherwise damaging the heart.
Moving now to FIGURE 6, there is illustrated another side view of the preferred embodiment of the present inventive lead further depicting the angle 15 between the tines and lead body 1 as well as the distance 11 between the distal end of lead body 1 and the base of the first row of tines 3, and also the distance 13 between the distal most point of the electrode tip 9 and the base of the second row of tines 7. In the preferred embodiment, the tines (3,7), extend from the lead body 1 at an acute angle from 30 to less than 90 as described in U.S. Patent No. 4,269,19~
issued to Stokes and commonly assigned with the present invention to Medtronic. However, in the preferred embodiment, the acute angles for both rows of tines (3,7) do not approach 90 simultaneously. At least one row of tines (3,7) will always have an acute angle substantially less than 90.
In the preferred embodiment, the distance 11 between the distal end of lead body 1 and the base of the first row of tines 3 is equal to or less than about four millimeters. The distance 13 between the distal most point of electrode tip 9 and the base of the second row of tines 7, illustrated in FIG. 6 of the preferred embodiment must be sufficient to adequately penetrate the myocardium to a depth not exceeding 4 mm. Furthermore, the tip 9 must not perforate the endocardium. The angular and dimensional criteria hereinbefore described and illustrated in FIG's 3-6 represent the preferred embodiment.
FIGURE 7 illustrates the preferred embodiment subsequent to implantation, further depicting active fixation of the present inventive lead assembly 10 following removal of the stylet used for guiding the lead assembly 10 into the myocardium. It can be seen that withdrawal of the stylet allows the preformed lead assembly 10 to assume its most stable right angle shape, thereby contributing to P-1972 8 2 ~ 0 6 2 ~ 7 66742-430 stabilization of the lead assembly 10 subsequent to implantation. Chronic removal is achieved by cutting the second row of tines 7 and then pulling the lead assembly 10 out by counter traction.
Obviously, many modifications and variations of the present invention are possible in light of the above teachings. For example, any body compatible material may be employed to form the exposed surface of the lead body and the tines, within the specified parameters. The number of tines may be varied according to preference and positioned around the periphery of a lead in accordance with known design considerations. The spacing between tine sets may be varied to address individual patient variations. In the illustrated embodiment, it is contemplated that four tines will be employed equidistantly positioned around the periphery of the lead. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
For example, a similar lead can be implanted transvenously to provide positive or passive fixation.
Positive fixation in this case would be achieved by applying slight pressure and rotating the lead until the tip pops into the myocardium as far as the second row of tines will allow.
Pa~sive fixation would be achieved by simply placing the lead as any other tined lead. Thus, in one lead, one can achieve the implant characteristics of an epicardial lead, a transvenous tined lead and a transvenous active fixation lead.
FIELD OF THE INVENTION
The pre~ent invention relates to a medical electrode lead and more particularly to a myocardial pacing lead employing a tip configuration to prevent excessive penetration into a patient's myocardium.
BACKGROUND OF THE INVENTION
Electrical ~timulation of the body for medical purposes i5 well known in the prior art. An example of a device for this purposs i8 the well known cardiac pacemaker. In general, pacemakers employ an electrode that is maintained in contact with a patient's heart muscle, through which electrical stimulation of the heart muscle is achieved. Such pacemakers commonly employ a flexible conductive lead that connects a remotely positioned and implanted power source to the electrode tip. The lead i8 typically routed to achieve either passive or active fixation to the heart muscle. Active fixation means such as corkscrew~ or hooks have been used to maintain the electrode tip in contact with the heart muscle.
Alternatively, passive fixation means have been employed to temporarily hold the electrode tip in contact with the heart muscle untll sufficient tissue ingrowth has occurred about the electrode tip to hold it in place. Such a passive device is disclosed in Citron et al. U.S. Pat. No. 3,902,501, who provide a plurality of pliant tines extending from the electrode adjacent the tip and forming an acute angle with respect to the electrode body. The tines cooperate with the trabeculae in the heart muscle to hold the electrode tip in position until such time as natural fixation has occurred.
Interactions between the lead and the patient's bcdy can vitiate the desired effects of the stimulation. For example, biolcgic reactions encourage fibrosis. Furthermore, trauma results in inflammation of the tissue to be stimulated. Other P-1972 2 2~6~
interactions between the lead and body, while not directly affecting the response of the tissue to the ~timulation energy, can result in the occurrence of undesirable svents.
The placement of a lead may compound certain events such as irritability.
Efforts have been made to ameliorate the undesirable consequences of interactions between lead and body. For example, leads have been configured to reduce mechanical trauma and the response of the irritable tissue during lead placement. Materials have been selected for the lead body and ele¢trodes to minimize fibrosis. However, lead configuration must take into account other factors such as the ease of placement, maintenance of the desired electrode position and the reliability of the lead over extended periods of time.
lS Undesirable interactions between lead and body are a particular problem in the context of a myocardial lead employing a penetrating electrode, especially in the area of pediatrics. Unlike the electrodes of most endocardial leads, penetrating myocardial electrodes are intended to function by insertion into the tissue, rather than by placement against the tissue. As such, the basic mode of operation of these electrodes requires some small amount of tissue damage to accompany attachment of the electrode. The greater the reaction of the heart tissue to this injury, the more likely it is that subsequent problems of increased threshold, fibrosis or irritability will rise. This is particularly true in the area of pediatrics. Thus, there is a need for a low threshold, high pacing impedance myocardial lead suitable for pediatrics.
SUMMARY OF THE INVENTION
The present invention provides a body implantable high impedance, low threshold, tined, myocardial lead for the delivery of stimulation energy suitable for use in adult and pediatric applications. In one embodiment, a high impedance, 3 ~ `7 low threshold, steroid eluting lead with a rough porous tip, includes two sets of at least two tines placed to oppose each other. The lead (with stylet) is pressed against the epicardium and is rotated. The rough porous tip abrades the epicardium and allows the tip and the first row of tines to penetrate the myocardium. Excessive penetration and lead migration is prevented by the second row of tines which is mounted backward and just proximal from the firæt row of tines. The first row of tines anchor on the inside surface of the epicardium thereby preventing dislodgment. Withdrawal of the stylet allows the lead to assume any existent preformed ~hape. Dacron pads on the second row oS tine~ assures chronic fixation by adhering to the outer surface o~ the patient~s epicardium. Controlling the depth of the first row of tines allows for chronic removal by counter traction without tearing or otherwise damaging the heart.
Another e~bodiment allows a similar lead to be implanted transvenously to provide positive or passive fixation.
Positive fixation is achieved by applying sliqht pressure and rotating the lead until the tip pops into the endocardium as far as the first row of tines will allow. Pas6ive fixation is achieved by simply placing the lead as any other prior art tined lead is placed.
Thus, the inventive lead can achieve the implant characteristics of an epicardial lead, a transvenous tined lead or a transvenous active fixation lead.
BRIEF DESCRIPTION OF THE DR~WINGS
FIG. 1 illustrates a side view of the distal end portion of a tined lead with a single row of tines as is already known in the prior art.
FIG. 2 illustrates active fixation of the distal end portion of the prior art tined lead depicted in FI~. 1 to a myocardium.
FIG. 3 illustrates a side view of the distal end portion of a preferred embodiment of the present invention.
FIG. 4 illustrates an end view of the distal end portion of a preferred embodiment of the present invention.
FIG. 5 illustrates active fixation of the distal end portion of a preferred embodiment of the present invention to a myocardium.
FIG. 6 illustrateæ another side view of the distal end portion of a preferred embodiment of the present invention depictlng optimal dimensional criteria.
FIG. 7 illustrates a preferred embodiment of the present lnvention ~ubsequent to active fixation to a myocardium and following removal of an insertion stylet, thereby allowing the preferred embodiment of the present invention to assume a stablQ preformed right angle shape.
DETAILED DESCRIPTION OF THE INVENTION
Referring now to FIGURE 1, there is illustrated a body implantable tined lead already known in the prior art. Tined leads such as this one are passively attached to heart muscle without penetrating the myocardium. An example of such a lead i8 disclosed in U.S. Patent Number 4,269,198 issued to Stokes.
Active fixation of a lead such as the lead invented by Stokes is illustrated in FIGURE 2. This type of application, with a single row of tines, has no means for preventing migration of the lead within the myocardium. Additionally, no means exist in such an application for controlling the depth of the lead into the myocardium for procuring active fixation.
Controlling the depth of active fixation into the myocardium and preventing migration of the lead tip subsequent to lead fixation become even more significant implant concerns in the area of pediatrics where patient organs are smaller and more fragile than fully developed adult organsO
Moving n~w to FIGURE 3, there is illustrated a side view of the distal end of a preferred embod-ment of the present 62~7 inventive lead capable of both controlling the depth of active fixation into a myocardium and preventing migration of the lead tip, effective in adult and paediatric applications. The proximal end, not shown, is coupled to an electrical connector such as those known in the prior art. The preferred embodiment, illustrated in FIGURE 3, also comprises an electrical conductor, not shown, within the insulating sheath 1. A tip electrode 9, preferably having a surface area less than 4.0 mm2, is provided at the distal end of the lead assembly 10 in a manner described in pending Canadian application Serial No. 2,085,369 for MINIATURE
STEROID ELUTING PACING LEAD ELECTRODES which has been assigned to Medtronic, Inc. Proximal to electrode 9, is a row of standard tines 3, identical to those shown in FIGURE 1 and already known in the prior art, formed of a pliant material which is generally inert to body fluids; silicone rubber or polyurethane, for example. The tines 3, are attached to the body member 1, in the traditional manner known in the prior art. The tines 3, may take any acute angle with the proximal end of body member 1, their purpose being to anchor to the inside wall of the epicardium, thereby preventing accidental dislodgment and maintaining the tip 9, in electrical contact with the myocardium. A second row of backward mounted tines 7, proximal the first row of tines 3, is located between the proximal end of lead assembly 10 and the first row of tines 3. The tines 7, in the second row must be longer than tines 3, in the first row to allow implantation into the myocardium. Tines 7 on the lead body 1 form an acute angle with body member 1 which is in opposition to the acute angle formed by tines 3 and body member 1. Additionally, tines 7 have dacron pads 5 attached to their free floating P-1972 6 ~ 2 ~ 7 ends for assuring chronic fixation of tines 7 to the outside wall of the epicardium.
Referring now to FIGURE 4, there is illustrated an end view of the preferred embodiment of the present inventive myocardial lead of FIGURE 3 as seen from the distal end containing tip electrode 9. Although four tines 3 are depicted in the first row, and four tines 7 are depicted in the ~econd row, any number of tines may be used, two or more being adequate in most situations. Furthermore, it is preferable to have the tines 3 in the first row alternately and evenly spaced with the tines 7 in the second row as indicated in FIG. 4, although such spacing and tine placement is not required for the present invention to function properly.
FIGURE S illustrates active fixation of the preferred embodiment of the present inventive tined myocardial pacing lead to a myocardium. Utilizing a stylet, the lead assembly 10 is pressed against the epicardium and is rotated. The rough porous tip 9 abrades the epicardium and allows the tip 9 and the first row of tines 3 to penetrate the myocardium.
The combination of pushing the tip electrode 9 toward the epicardium while rotating the electrode 9 at the same time r~sults in only a gentle and significantly less force required to perforate the epicardium as compared to simply pushing the electrode 9 into the epicardium to achieve myocardial penetration. Excessive penetration into the myocardium i8 prevented by the second row of tines 7. The first row of tines 3 anchor on the inside wall of the epicardium thereby preventing accidental dislodgment without use of sufficient external force. Chronic fixation of the lead assembly 10 is achi2vsd by dacron pads 5 which adhere to the outside wall of the epi~ardium in as a result of fibrosis Thus, controlling the dep~h of tip electrode 9 penetration into the myocardium, thereby ensuring the anchoring position of the first row of tines 3, further ensures that chronic removal of lead assembly 2~0~2~7 10 by counter traction can be accomplished without tearing or otherwise damaging the heart.
Moving now to FIGURE 6, there is illustrated another side view of the preferred embodiment of the present inventive lead further depicting the angle 15 between the tines and lead body 1 as well as the distance 11 between the distal end of lead body 1 and the base of the first row of tines 3, and also the distance 13 between the distal most point of the electrode tip 9 and the base of the second row of tines 7. In the preferred embodiment, the tines (3,7), extend from the lead body 1 at an acute angle from 30 to less than 90 as described in U.S. Patent No. 4,269,19~
issued to Stokes and commonly assigned with the present invention to Medtronic. However, in the preferred embodiment, the acute angles for both rows of tines (3,7) do not approach 90 simultaneously. At least one row of tines (3,7) will always have an acute angle substantially less than 90.
In the preferred embodiment, the distance 11 between the distal end of lead body 1 and the base of the first row of tines 3 is equal to or less than about four millimeters. The distance 13 between the distal most point of electrode tip 9 and the base of the second row of tines 7, illustrated in FIG. 6 of the preferred embodiment must be sufficient to adequately penetrate the myocardium to a depth not exceeding 4 mm. Furthermore, the tip 9 must not perforate the endocardium. The angular and dimensional criteria hereinbefore described and illustrated in FIG's 3-6 represent the preferred embodiment.
FIGURE 7 illustrates the preferred embodiment subsequent to implantation, further depicting active fixation of the present inventive lead assembly 10 following removal of the stylet used for guiding the lead assembly 10 into the myocardium. It can be seen that withdrawal of the stylet allows the preformed lead assembly 10 to assume its most stable right angle shape, thereby contributing to P-1972 8 2 ~ 0 6 2 ~ 7 66742-430 stabilization of the lead assembly 10 subsequent to implantation. Chronic removal is achieved by cutting the second row of tines 7 and then pulling the lead assembly 10 out by counter traction.
Obviously, many modifications and variations of the present invention are possible in light of the above teachings. For example, any body compatible material may be employed to form the exposed surface of the lead body and the tines, within the specified parameters. The number of tines may be varied according to preference and positioned around the periphery of a lead in accordance with known design considerations. The spacing between tine sets may be varied to address individual patient variations. In the illustrated embodiment, it is contemplated that four tines will be employed equidistantly positioned around the periphery of the lead. It is therefore to be understood that, within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
For example, a similar lead can be implanted transvenously to provide positive or passive fixation.
Positive fixation in this case would be achieved by applying slight pressure and rotating the lead until the tip pops into the myocardium as far as the second row of tines will allow.
Pa~sive fixation would be achieved by simply placing the lead as any other tined lead. Thus, in one lead, one can achieve the implant characteristics of an epicardial lead, a transvenous tined lead and a transvenous active fixation lead.
Claims (20)
1. A myocardial pacing lead comprising:
an electrical conductor having a proximal end and a distal end;
insulating sheath means for covering said conductor between said proximal and distal end of said conductor thereof;
electrical connector means coupled to said proximal end of said conductor;
electrode means electrically coupled to said distal end of said electrical conductor for conducting electrical energy to and from body tissue cells;
first tine means extending from said insulating sheath means proximal said electrode, said first tine means forming an acute angle with said proximal end of said conductor; and second tine means extending from said insulating sheath means proximal said first tine means and located between said first tine means and said proximal end of said conductor, said second tine means forming an acute angle with said distal end of said conductor.
an electrical conductor having a proximal end and a distal end;
insulating sheath means for covering said conductor between said proximal and distal end of said conductor thereof;
electrical connector means coupled to said proximal end of said conductor;
electrode means electrically coupled to said distal end of said electrical conductor for conducting electrical energy to and from body tissue cells;
first tine means extending from said insulating sheath means proximal said electrode, said first tine means forming an acute angle with said proximal end of said conductor; and second tine means extending from said insulating sheath means proximal said first tine means and located between said first tine means and said proximal end of said conductor, said second tine means forming an acute angle with said distal end of said conductor.
2. The lead of claim 1 wherein said first tine means comprises a first plurality of pliable tines.
3. The lead of claim 2 wherein said first plurality of tines are spaced proximally equal to or less than about 4 millimeters from said distal end of said conductor;
4. The lead of claim 3 wherein said acute angle of said first tine means is from 30° to less than 90°.
5. The lead of claim 4 wherein said acute angle of said first tine means is from 30° to 80°.
6. The lead of claim 5 wherein said acute angle of said first tine means is from 45° to 60°.
7. The lead of claim 4 wherein said second tine means further comprises a dacron pad attached to a free floating end of each of said tines.
8. The lead of claim 5 wherein said second tine means further comprises a dacron pad attached to a free floating end of each of said tines.
9. The lead of claim 6 wherein said second tine means further comprises a dacron pad attached to a free floating end of each of said tines.
10. The lead of claim 4 wherein said second tine means comprises a second plurality of pliable tines;
11. The lead of claim 10 wherein said acute angle of second tine means is 30° to 80°.
12. The lead of claim 11 wherein said acute angle of said second tine means is 45° to 60°.
13. The lead of claim 5 wherein said second tine means comprises a second plurality of pliable tines;
14. The lead of claim 13 wherein said acute angle of second tine means is 30° to 90°.
15. The lead of claim 6 wherein said second tine means comprises a second plurality of pliable tines;
16. The lead of claim 15 wherein said acute angle of second tine means is 30° to 90°.
17. The lead of claim 16 wherein said acute angle of second tine means is 30° to 80°.
18. The lead of claim 10 wherein said second plurality of tines are spaced proximally less than about 20 millimeters from a distal end of said insulating sheath, said distal end of said insulating sheath covering said distal end of said conductor.
19. The lead of claim 13 wherein said second plurality of tines are spaced proximally less than about 20 millimeters from a distal end of said insulating sheath, said distal end of said insulating sheath covering said distal end of said conductor.
20. The lead of claim 15 wherein said second plurality of tines are spaced proximally less than about 20 millimeters from a distal end of said insulating sheath, said distal end of said insulating sheath covering said distal end of said conductor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/964,737 US5300107A (en) | 1992-10-22 | 1992-10-22 | Universal tined myocardial pacing lead |
| US07/964,737 | 1992-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2106257A1 true CA2106257A1 (en) | 1994-04-23 |
Family
ID=25508912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002106257A Abandoned CA2106257A1 (en) | 1992-10-22 | 1993-09-15 | Universal tined myocardial pacing lead |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5300107A (en) |
| EP (1) | EP0596625A1 (en) |
| JP (1) | JPH0716299A (en) |
| AU (1) | AU4735693A (en) |
| CA (1) | CA2106257A1 (en) |
Families Citing this family (189)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19611777C2 (en) * | 1996-03-14 | 2001-09-27 | Biotronik Mess & Therapieg | Arrangement for electrical contacting |
| US6381495B1 (en) * | 1997-05-28 | 2002-04-30 | Transneuronix, Inc. | Medical device for use in laparoscopic surgery |
| FR2777465B1 (en) * | 1998-04-15 | 2000-06-09 | Ela Medical Sa | INCREASED IMPEDANCE PROBE FOR IMPLANTED MEDICAL DEVICE, PARTICULARLY FOR HEART STIMULATOR |
| US6148238A (en) * | 1998-08-10 | 2000-11-14 | Medtronic, Inc. | Pacing leads having a brachiocephalic tine or star tine |
| DE69921447T2 (en) | 1999-04-02 | 2005-11-24 | Sorin Biomedica Crm S.R.L., Saluggia | Anchor structure for implantable electrodes |
| US6405091B1 (en) * | 1999-07-20 | 2002-06-11 | Pacesetter, Inc. | Lead assembly with masked microdisk tip electrode and monolithic controlled release device |
| US6434431B1 (en) * | 2000-01-20 | 2002-08-13 | Medtronic, Inc. | Intramuscular medical electrical lead with fixation member |
| US6684109B1 (en) * | 2000-09-13 | 2004-01-27 | Oscor Inc. | Endocardial lead |
| US6535764B2 (en) * | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
| US6999819B2 (en) | 2001-08-31 | 2006-02-14 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
| US6745079B2 (en) * | 2001-11-07 | 2004-06-01 | Medtronic, Inc. | Electrical tissue stimulation apparatus and method |
| US6978185B2 (en) * | 2001-11-09 | 2005-12-20 | Oscor Inc. | Multifilar conductor for cardiac leads |
| US7546166B2 (en) * | 2001-11-29 | 2009-06-09 | Medtronic, Inc. | Medical lead designs for lead placement through tissue |
| US20030105501A1 (en) * | 2001-12-03 | 2003-06-05 | Warman Eduardo N. | Shaped lead with electrodes |
| US8301248B1 (en) | 2002-03-06 | 2012-10-30 | Boston Scientific Neuromodulation Corporation | Sequenced and simultaneous stimulation for treating congestive heart failure |
| US7120504B2 (en) * | 2002-07-25 | 2006-10-10 | Oscor Inc. | Epicardial screw-in lead |
| US7369894B2 (en) * | 2002-09-06 | 2008-05-06 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves |
| US7427280B2 (en) | 2002-09-06 | 2008-09-23 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues |
| US7328069B2 (en) * | 2002-09-06 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves |
| US7276057B2 (en) * | 2002-09-06 | 2007-10-02 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by drug delivery to the pudendal and sacral nerves |
| US7328068B2 (en) * | 2003-03-31 | 2008-02-05 | Medtronic, Inc. | Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith |
| US7615010B1 (en) | 2002-10-03 | 2009-11-10 | Integrated Sensing Systems, Inc. | System for monitoring the physiologic parameters of patients with congestive heart failure |
| DE10316177B4 (en) * | 2003-04-10 | 2007-05-31 | Cardiac Pacemakers, Inc., St. Paul | Pacemaker electrode arrangement |
| US7742818B2 (en) * | 2003-05-19 | 2010-06-22 | Medtronic, Inc. | Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof |
| US7620454B2 (en) | 2003-05-19 | 2009-11-17 | Medtronic, Inc. | Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof |
| US7317951B2 (en) * | 2003-07-25 | 2008-01-08 | Integrated Sensing Systems, Inc. | Anchor for medical implant placement and method of manufacture |
| US7343202B2 (en) * | 2004-02-12 | 2008-03-11 | Ndi Medical, Llc. | Method for affecting urinary function with electrode implantation in adipose tissue |
| US7813809B2 (en) * | 2004-06-10 | 2010-10-12 | Medtronic, Inc. | Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US7418292B2 (en) * | 2003-10-01 | 2008-08-26 | Medtronic, Inc. | Device and method for attenuating an immune response |
| US20050075702A1 (en) * | 2003-10-01 | 2005-04-07 | Medtronic, Inc. | Device and method for inhibiting release of pro-inflammatory mediator |
| EP1682215B1 (en) * | 2003-10-24 | 2008-12-24 | Cardiac Pacemakers, Inc. | Myocardial lead attachment system |
| US7499759B2 (en) * | 2003-10-24 | 2009-03-03 | Cardiac Pacemakers, Inc. | Distal or proximal fixation of over-the-tether myocardial leads |
| US7212869B2 (en) * | 2004-02-04 | 2007-05-01 | Medtronic, Inc. | Lead retention means |
| US8467875B2 (en) | 2004-02-12 | 2013-06-18 | Medtronic, Inc. | Stimulation of dorsal genital nerves to treat urologic dysfunctions |
| US20080161874A1 (en) * | 2004-02-12 | 2008-07-03 | Ndi Medical, Inc. | Systems and methods for a trial stage and/or long-term treatment of disorders of the body using neurostimulation |
| US9205255B2 (en) * | 2004-06-10 | 2015-12-08 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US7761167B2 (en) | 2004-06-10 | 2010-07-20 | Medtronic Urinary Solutions, Inc. | Systems and methods for clinician control of stimulation systems |
| US8165692B2 (en) * | 2004-06-10 | 2012-04-24 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator power management |
| US9308382B2 (en) | 2004-06-10 | 2016-04-12 | Medtronic Urinary Solutions, Inc. | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| US20070066995A1 (en) * | 2004-06-10 | 2007-03-22 | Ndi Medical, Llc | Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue |
| CA2566614A1 (en) * | 2004-06-10 | 2005-12-29 | Ndi Medical, Llc | Systems and methods for bilateral stimulation of left and right branches of the dorsal genital nerves to treat dysfunctions, such as urinary incontinence |
| US8195304B2 (en) | 2004-06-10 | 2012-06-05 | Medtronic Urinary Solutions, Inc. | Implantable systems and methods for acquisition and processing of electrical signals |
| CA2583404A1 (en) | 2004-10-20 | 2006-04-27 | Boston Scientific Limited | Leadless cardiac stimulation systems |
| US7532933B2 (en) * | 2004-10-20 | 2009-05-12 | Boston Scientific Scimed, Inc. | Leadless cardiac stimulation systems |
| US7650186B2 (en) * | 2004-10-20 | 2010-01-19 | Boston Scientific Scimed, Inc. | Leadless cardiac stimulation systems |
| US8489189B2 (en) * | 2004-10-29 | 2013-07-16 | Medtronic, Inc. | Expandable fixation mechanism |
| US20060095077A1 (en) * | 2004-10-29 | 2006-05-04 | Tronnes Carole A | Expandable fixation structures |
| US7463932B2 (en) * | 2005-01-14 | 2008-12-09 | Cardiac Pacemakers, Inc. | Fastening device for an epicardial lead |
| US7450999B1 (en) * | 2005-02-07 | 2008-11-11 | Pacesetter, Inc. | Trans-septal intra-cardiac lead system |
| US7389134B1 (en) | 2005-02-07 | 2008-06-17 | Pacesetter, Inc. | Trans-septal intra-cardiac lead system |
| US7274965B1 (en) | 2005-02-07 | 2007-09-25 | Pacesetter, Inc. | Trans-septal intra-cardiac lead system |
| US7448999B1 (en) | 2005-02-07 | 2008-11-11 | Pacesetter, Inc. | Trans-septal intra-cardiac lead system |
| US7340288B1 (en) | 2005-02-07 | 2008-03-04 | Pacesetter, Inc. | Trans-septal intra-cardiac lead system |
| US7321798B2 (en) * | 2005-03-31 | 2008-01-22 | Medtronic, Inc. | Trans-septal/trans-myocardial ventricular pacing lead |
| US8391990B2 (en) | 2005-05-18 | 2013-03-05 | Cardiac Pacemakers, Inc. | Modular antitachyarrhythmia therapy system |
| US20070049980A1 (en) * | 2005-08-30 | 2007-03-01 | Zielinski Todd M | Trans-septal pressure sensor |
| US20070106358A1 (en) * | 2005-11-04 | 2007-05-10 | Cardiac Pacemakers, Inc. | Tissue stimulating lead and method of implantation and manufacture |
| ATE493167T1 (en) | 2005-12-09 | 2011-01-15 | Boston Scient Scimed Inc | CARDIAC STIMULATION SYSTEM |
| US8050774B2 (en) * | 2005-12-22 | 2011-11-01 | Boston Scientific Scimed, Inc. | Electrode apparatus, systems and methods |
| US7418868B1 (en) | 2006-02-21 | 2008-09-02 | Pacesetter, Inc. | Pressure sensor and method of fabricating such a module |
| US7937161B2 (en) * | 2006-03-31 | 2011-05-03 | Boston Scientific Scimed, Inc. | Cardiac stimulation electrodes, delivery devices, and implantation configurations |
| US20070255333A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Neuromodulation therapy for perineal or dorsal branch of pudendal nerve |
| US9480846B2 (en) | 2006-05-17 | 2016-11-01 | Medtronic Urinary Solutions, Inc. | Systems and methods for patient control of stimulation systems |
| US7734341B2 (en) * | 2006-06-06 | 2010-06-08 | Cardiac Pacemakers, Inc. | Method and apparatus for gastrointestinal stimulation via the lymphatic system |
| US7840281B2 (en) | 2006-07-21 | 2010-11-23 | Boston Scientific Scimed, Inc. | Delivery of cardiac stimulation devices |
| US8290600B2 (en) * | 2006-07-21 | 2012-10-16 | Boston Scientific Scimed, Inc. | Electrical stimulation of body tissue using interconnected electrode assemblies |
| JP5537939B2 (en) | 2006-08-30 | 2014-07-02 | サーキュライト・インコーポレーテッド | Apparatus, method and system for establishing supplemental blood flow in the circulatory system |
| US8333686B2 (en) * | 2006-08-30 | 2012-12-18 | Circulite, Inc. | Cannula insertion devices, systems, and methods including a compressible member |
| US7905823B2 (en) | 2006-08-30 | 2011-03-15 | Circulite, Inc. | Devices, methods and systems for establishing supplemental blood flow in the circulatory system |
| US8644934B2 (en) * | 2006-09-13 | 2014-02-04 | Boston Scientific Scimed Inc. | Cardiac stimulation using leadless electrode assemblies |
| US8688238B2 (en) * | 2006-10-31 | 2014-04-01 | Medtronic, Inc. | Implantable medical elongated member including fixation elements along an interior surface |
| US7684873B2 (en) * | 2006-10-31 | 2010-03-23 | Medtronic, Inc. | Implantable medical lead including a directional electrode and fixation elements along an interior surface |
| US20080103576A1 (en) * | 2006-10-31 | 2008-05-01 | Medtronic, Inc. | Implantable medical elongated member including expandable fixation member |
| US8267863B2 (en) * | 2007-04-30 | 2012-09-18 | Integrated Sensing Systems, Inc. | Procedure and system for monitoring a physiological parameter within an internal organ of a living body |
| WO2008140365A1 (en) * | 2007-05-15 | 2008-11-20 | St. Jude Medical Ab | Medical implantable lead with pivoting segments |
| US20090259280A1 (en) * | 2007-10-15 | 2009-10-15 | Kevin Wilkin | Electrical stimulation lead with bioerodible anchors and anchor straps |
| US8343029B2 (en) * | 2007-10-24 | 2013-01-01 | Circulite, Inc. | Transseptal cannula, tip, delivery system, and method |
| JP5153892B2 (en) | 2008-02-07 | 2013-02-27 | カーディアック ペースメイカーズ， インコーポレイテッド | Wireless tissue electrical stimulation |
| US8460168B2 (en) * | 2009-03-27 | 2013-06-11 | Circulite, Inc. | Transseptal cannula device, coaxial balloon delivery device, and methods of using the same |
| US20100249491A1 (en) * | 2009-03-27 | 2010-09-30 | Circulite, Inc. | Two-piece transseptal cannula, delivery system, and method of delivery |
| US8308715B2 (en) * | 2009-11-13 | 2012-11-13 | Circulite, Inc. | Cannula stabilizer |
| US8948882B2 (en) | 2010-08-25 | 2015-02-03 | Medtronic, Inc. | Fixation components for implantable medical devices and associated device construction |
| US10071243B2 (en) | 2013-07-31 | 2018-09-11 | Medtronic, Inc. | Fixation for implantable medical devices |
| US10842993B2 (en) | 2013-08-16 | 2020-11-24 | Cardiac Pacemakers, Inc. | Leadless cardiac pacing devices |
| US9492674B2 (en) | 2013-08-16 | 2016-11-15 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with delivery and/or retrieval features |
| US9393427B2 (en) | 2013-08-16 | 2016-07-19 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with delivery and/or retrieval features |
| US10722723B2 (en) | 2013-08-16 | 2020-07-28 | Cardiac Pacemakers, Inc. | Delivery devices and methods for leadless cardiac devices |
| US9480850B2 (en) | 2013-08-16 | 2016-11-01 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker and retrieval device |
| CN105451812B (en) | 2013-08-16 | 2017-09-08 | 心脏起搏器股份公司 | Transmission equipment and method for leadless cardiac equipment |
| BR112016003148B1 (en) | 2013-08-16 | 2021-01-12 | Cardiac Pacemakers, Inc. | non-shunt cardiac pacing devices |
| CN105744987B (en) | 2013-08-16 | 2019-01-15 | 心脏起搏器股份公司 | Leadless cardiac pacemaker and fetch equipment |
| CN106102830B (en) | 2014-01-10 | 2019-07-16 | 心脏起搏器股份公司 | For improving the method and system of the communication between medical device |
| US9592391B2 (en) | 2014-01-10 | 2017-03-14 | Cardiac Pacemakers, Inc. | Systems and methods for detecting cardiac arrhythmias |
| US10004913B2 (en) | 2014-03-03 | 2018-06-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for power conversion and data transmission in implantable sensors, stimulators, and actuators |
| WO2015168153A1 (en) | 2014-04-29 | 2015-11-05 | Cardiac Pacemakers, Inc. | Leadless cardiac pacing devices including tissue engagement verification |
| US9795781B2 (en) | 2014-04-29 | 2017-10-24 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with retrieval features |
| US10434329B2 (en) | 2014-05-09 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Autofocus wireless power transfer to implantable devices in freely moving animals |
| US9526909B2 (en) | 2014-08-28 | 2016-12-27 | Cardiac Pacemakers, Inc. | Medical device with triggered blanking period |
| US9764127B2 (en) | 2014-12-19 | 2017-09-19 | Cardiac Pacemakers, Inc. | Medical lead anchoring |
| AU2016215606B2 (en) | 2015-02-06 | 2018-05-31 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| ES2713231T3 (en) | 2015-02-06 | 2019-05-20 | Cardiac Pacemakers Inc | Systems for the safe supply of electrical stimulation therapy |
| US10046167B2 (en) | 2015-02-09 | 2018-08-14 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
| WO2016137855A1 (en) * | 2015-02-24 | 2016-09-01 | Med-El Elektromedizinische Geraete Gmbh | Active fixation of neural tissue electrodes |
| WO2016141046A1 (en) | 2015-03-04 | 2016-09-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
| JP6515195B2 (en) | 2015-03-18 | 2019-05-15 | カーディアック ペースメイカーズ， インコーポレイテッド | Implantable medical device and medical system |
| CN108136187B (en) | 2015-08-20 | 2021-06-29 | 心脏起搏器股份公司 | System and method for communication between medical devices |
| US9853743B2 (en) | 2015-08-20 | 2017-12-26 | Cardiac Pacemakers, Inc. | Systems and methods for communication between medical devices |
| US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
| US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
| US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
| US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
| US10137305B2 (en) | 2015-08-28 | 2018-11-27 | Cardiac Pacemakers, Inc. | Systems and methods for behaviorally responsive signal detection and therapy delivery |
| WO2017044389A1 (en) | 2015-09-11 | 2017-03-16 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
| WO2017062806A1 (en) | 2015-10-08 | 2017-04-13 | Cardiac Pacemakers, Inc. | Devices and methods for adjusting pacing rates in an implantable medical device |
| WO2017106693A1 (en) | 2015-12-17 | 2017-06-22 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
| US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
| US10624554B2 (en) * | 2016-01-14 | 2020-04-21 | Biosense Webster (Israel) Ltd. | Non-overlapping loop-type or spline-type catheter to determine activation source direction and activation source type |
| US11006887B2 (en) | 2016-01-14 | 2021-05-18 | Biosense Webster (Israel) Ltd. | Region of interest focal source detection using comparisons of R-S wave magnitudes and LATs of RS complexes |
| WO2017127548A1 (en) | 2016-01-19 | 2017-07-27 | Cardiac Pacemakers, Inc. | Devices for wirelessly recharging a rechargeable battery of an implantable medical device |
| US10099050B2 (en) | 2016-01-21 | 2018-10-16 | Medtronic, Inc. | Interventional medical devices, device systems, and fixation components thereof |
| US10463853B2 (en) | 2016-01-21 | 2019-11-05 | Medtronic, Inc. | Interventional medical systems |
| EP3411113B1 (en) | 2016-02-04 | 2019-11-27 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
| EP4395124A3 (en) | 2016-03-21 | 2024-07-31 | Nalu Medical, Inc. | Devices and methods for positioning external devices in relation to implanted devices |
| US11116988B2 (en) | 2016-03-31 | 2021-09-14 | Cardiac Pacemakers, Inc. | Implantable medical device with rechargeable battery |
| US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
| US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
| US10512784B2 (en) | 2016-06-27 | 2019-12-24 | Cardiac Pacemakers, Inc. | Cardiac therapy system using subcutaneously sensed P-waves for resynchronization pacing management |
| US11207527B2 (en) | 2016-07-06 | 2021-12-28 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
| WO2018009392A1 (en) | 2016-07-07 | 2018-01-11 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
| WO2018017463A1 (en) | 2016-07-18 | 2018-01-25 | Nalu Medical, Inc. | Methods and systems for treating pelvic disorders and pain conditions |
| US10688304B2 (en) | 2016-07-20 | 2020-06-23 | Cardiac Pacemakers, Inc. | Method and system for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
| CN109562269B (en) | 2016-08-19 | 2023-08-11 | 心脏起搏器股份公司 | Transseptal implantable medical device |
| WO2018039322A1 (en) | 2016-08-24 | 2018-03-01 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
| WO2018039335A1 (en) | 2016-08-24 | 2018-03-01 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing |
| US10994145B2 (en) | 2016-09-21 | 2021-05-04 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
| WO2018057318A1 (en) | 2016-09-21 | 2018-03-29 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
| US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
| US10238865B2 (en) | 2016-10-06 | 2019-03-26 | Medtronic, Inc. | Electrode fixation in interventional medical systems |
| WO2018081133A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
| US10463305B2 (en) | 2016-10-27 | 2019-11-05 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
| US10434314B2 (en) | 2016-10-27 | 2019-10-08 | Cardiac Pacemakers, Inc. | Use of a separate device in managing the pace pulse energy of a cardiac pacemaker |
| US10328257B2 (en) | 2016-10-27 | 2019-06-25 | Medtronic, Inc. | Electrode fixation in interventional medical systems |
| US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
| EP3532161B1 (en) | 2016-10-27 | 2023-08-30 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
| WO2018081225A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
| EP3532158B1 (en) | 2016-10-31 | 2022-12-14 | Cardiac Pacemakers, Inc. | Systems for activity level pacing |
| JP6719024B2 (en) | 2016-10-31 | 2020-07-08 | カーディアック ペースメイカーズ， インコーポレイテッド | Implantable medical device for activity level pacing |
| WO2018089311A1 (en) | 2016-11-08 | 2018-05-17 | Cardiac Pacemakers, Inc | Implantable medical device for atrial deployment |
| EP3538213B1 (en) | 2016-11-09 | 2023-04-12 | Cardiac Pacemakers, Inc. | Systems and devices for setting cardiac pacing pulse parameters for a cardiac pacing device |
| EP3541471B1 (en) | 2016-11-21 | 2021-01-20 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker providing cardiac resynchronization therapy |
| US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
| US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
| CN109996585B (en) | 2016-11-21 | 2023-06-13 | 心脏起搏器股份公司 | Implantable medical device with magnetically permeable housing and induction coil disposed around the housing |
| WO2018094344A2 (en) | 2016-11-21 | 2018-05-24 | Cardiac Pacemakers, Inc | Leadless cardiac pacemaker with multimode communication |
| US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
| US10737102B2 (en) | 2017-01-26 | 2020-08-11 | Cardiac Pacemakers, Inc. | Leadless implantable device with detachable fixation |
| WO2018140623A1 (en) | 2017-01-26 | 2018-08-02 | Cardiac Pacemakers, Inc. | Leadless device with overmolded components |
| AU2018213326B2 (en) | 2017-01-26 | 2020-09-10 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
| EP3585475B1 (en) | 2017-02-24 | 2024-04-03 | Nalu Medical, Inc. | Apparatus with sequentially implanted stimulators |
| WO2018187121A1 (en) | 2017-04-03 | 2018-10-11 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate |
| US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
| WO2018208992A1 (en) | 2017-05-09 | 2018-11-15 | Nalu Medical, Inc. | Stimulation apparatus |
| US10918875B2 (en) | 2017-08-18 | 2021-02-16 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
| EP3668592B1 (en) | 2017-08-18 | 2021-11-17 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
| JP6938778B2 (en) | 2017-09-20 | 2021-09-22 | カーディアック ペースメイカーズ， インコーポレイテッド | Implantable medical device with multiple modes of operation |
| US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
| CN111417433B (en) | 2017-12-01 | 2024-04-30 | 心脏起搏器股份公司 | Method and system for detecting atrial contraction timing reference during ventricular filling from ventricular implanted leadless cardiac pacemaker |
| US11813463B2 (en) | 2017-12-01 | 2023-11-14 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with reversionary behavior |
| CN111432874A (en) | 2017-12-01 | 2020-07-17 | 心脏起搏器股份公司 | Method and system for detecting atrial contraction timing reference within search window from a ventricular implanted leadless cardiac pacemaker |
| US11071870B2 (en) | 2017-12-01 | 2021-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
| CN111556773A (en) | 2018-01-04 | 2020-08-18 | 心脏起搏器股份公司 | Dual chamber pacing without beat-to-beat communication |
| US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
| US11235159B2 (en) | 2018-03-23 | 2022-02-01 | Medtronic, Inc. | VFA cardiac resynchronization therapy |
| EP3768369A1 (en) | 2018-03-23 | 2021-01-27 | Medtronic, Inc. | Av synchronous vfa cardiac therapy |
| CN111936046B (en) | 2018-03-23 | 2024-06-28 | 美敦力公司 | VFA heart treatment for tachycardia |
| US11235161B2 (en) | 2018-09-26 | 2022-02-01 | Medtronic, Inc. | Capture in ventricle-from-atrium cardiac therapy |
| US11951313B2 (en) | 2018-11-17 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
| US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
| US11759632B2 (en) | 2019-03-28 | 2023-09-19 | Medtronic, Inc. | Fixation components for implantable medical devices |
| US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
| US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
| US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
| US11065461B2 (en) | 2019-07-08 | 2021-07-20 | Bioness Inc. | Implantable power adapter |
| US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
| US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
| US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
| US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
| WO2023059711A2 (en) * | 2021-10-07 | 2023-04-13 | W. L. Gore & Associates, Inc. | Inflow / outflow cannula |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3902501A (en) * | 1973-06-21 | 1975-09-02 | Medtronic Inc | Endocardial electrode |
| EP0004967A3 (en) * | 1978-04-17 | 1979-11-14 | Mohl, Werner, Prof. DDr. | Anchoring means for a probe head, particularly a cardiac probe |
| US4269198A (en) * | 1979-12-26 | 1981-05-26 | Medtronic, Inc. | Body implantable lead |
| DE3015260A1 (en) * | 1980-04-21 | 1981-10-22 | Siemens AG, 1000 Berlin und 8000 München | ENDOCARD ELECTRODE ARRANGEMENT |
| US4585013A (en) * | 1981-04-20 | 1986-04-29 | Cordis Corporation | Lumenless pervenous electrical lead and method of implantation |
| US4549557A (en) * | 1983-11-01 | 1985-10-29 | Hakki A Hadi I | Pacemaker electrode |
| US4590949A (en) * | 1984-11-01 | 1986-05-27 | Cordis Corporation | Neural stimulating lead with stabilizing mechanism and method for using same |
| US4716888A (en) * | 1985-06-17 | 1988-01-05 | Cordis Corporation | Tined leads |
| US4658835A (en) * | 1985-07-25 | 1987-04-21 | Cordis Corporation | Neural stimulating lead with fixation canopy formation |
| US4722353A (en) * | 1985-09-16 | 1988-02-02 | Intermedics, Inc. | Stabilizer for implantable electrode |
| US4796643A (en) * | 1986-09-30 | 1989-01-10 | Telectronics N.V. | Medical electrode leads |
-
1992
- 1992-10-22 US US07/964,737 patent/US5300107A/en not_active Expired - Lifetime
-
1993
- 1993-09-14 AU AU47356/93A patent/AU4735693A/en not_active Abandoned
- 1993-09-15 CA CA002106257A patent/CA2106257A1/en not_active Abandoned
- 1993-10-21 EP EP93308372A patent/EP0596625A1/en not_active Withdrawn
- 1993-10-22 JP JP5286208A patent/JPH0716299A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0596625A1 (en) | 1994-05-11 |
| AU4735693A (en) | 1994-05-05 |
| JPH0716299A (en) | 1995-01-20 |
| US5300107A (en) | 1994-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5300107A (en) | Universal tined myocardial pacing lead | |
| US6078840A (en) | Medical electrical lead having improved fixation | |
| US4998975A (en) | Travenously placed defibrillation leads | |
| US7177704B2 (en) | Pacing method and apparatus | |
| US7139614B2 (en) | Leads for pacing and/or sensing the heart from within the coronary veins | |
| US6141594A (en) | Single pass lead and system with active and passive fixation elements | |
| US5383922A (en) | RF lead fixation and implantable lead | |
| US6584363B2 (en) | Implantable lead with dissolvable coating for improved fixation and extraction | |
| US4628944A (en) | Cardiac pacing lead with biodegradable fixation structure | |
| US6363286B1 (en) | High impedance electrode assembly | |
| US6842648B2 (en) | System and assembly having conductive fixation features | |
| US5800497A (en) | Medical electrical lead with temporarily stiff portion | |
| US5755767A (en) | Anti-dislodgment and anti-perforation distal tip design for transvenous lead | |
| US7212870B1 (en) | Dual helix active fixation stimulation lead | |
| US4922927A (en) | Transvenous defibrillating and pacing lead | |
| US5476500A (en) | Endocardial lead system with defibrillation electrode fixation | |
| US5154182A (en) | Drug or steroid releasing patch electrode for an implantable arrhythmia treatment system | |
| US20040133259A1 (en) | High impedance electrode tip | |
| US20040176830A1 (en) | Epicardial electrode | |
| EP0979664A2 (en) | Atrial fixation/stimulation loop | |
| EP1441806A2 (en) | Cardiac lead with steroid eluting ring | |
| US5154183A (en) | Bipolar myocardial electrode assembly | |
| EP0085967B1 (en) | Cardiac pacing lead with biodegradable fixation means | |
| US6148238A (en) | Pacing leads having a brachiocephalic tine or star tine | |
| EP0979665A2 (en) | Flexible and adjustable DDD lead |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |